Search
for
Sort by
Research 391–420 of 579
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Alopecia areata, actualización clínica y terapéutica
- Central Centrifugal Cicatricial Alopecia (CCCA): Unraveling the Complexities of a Scarring Hair Disorder
- TNC+ fibroblasts involve in skin inflammation via neuro-immune and interacting with T cells
- Common Causes of Hair Loss and Their Treatment Options
- Ginger Extract Reduces Oxidative Stress and Improves the Clinical Outcomes in Patients with Alopecia Areata
- Recent advances in the genetics of alopecia areata
- Retrospektive Analyse von Wirksamkeit, Sicherheit, prognostischen Parametern und Faktoren der Lebensqualität bei der topischen Immuntherapie der Alopecia areata mit Diphenylcyclopropenon
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
- Recommendations on trichological treatments during COVID-19 pandemic
- Phytochemicals as emerging therapeutic agents for alopecia treatment
- Free Papers Medical and Surgical: Hair and Nails
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Contents Vol. 4, 2018
- Table of Contents
- Etiopathogenesis of Alopecia Areata
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- Upadacitinib for the treatment of alopecia areata – A case report
- This Month in JAAD: October 2021
- Quoi de neuf en dermatologie pédiatrique ?
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases